酵素阻害剤としての二次元金属有機枠ナノシート:α-キモトリプシン活動の調節
Ming Xu1, Shuai Yuan2, Xin-Yu Chen1
1Jiangsu Key Laboratory of Biofunctional Materials, Jiangsu Collaborative Innovation Center of Biomedical Functional Materials, College of Chemistry and Materials Science, Nanjing Normal University , Nanjing, 210023, China.
Journal of the American Chemical Society
|May 25, 2017
まとめ
二次元金属有機フレームワーク (MOF) ナノシートは,活性サイトを遮断することによってα-キモトリプシン (ChT) を効果的に阻害します. この発見は,MOF-酵素の相互作用と 細胞プロセスを制御する新しい洞察を提供します.
科学分野:
- 生物化学
- 材料科学
- ナノテクノロジー
背景:
- 二次元金属有機フレームワーク (MOF) のナノシートは,生物学的システムにおける新しい応用を提供します.
- MOFと酵素の間のインターフェースを理解することは,細胞のプロセスを制御するために不可欠です.
研究 の 目的:
- α-キモトリプシン (ChT) の活性に対する2DMOFナノシートの抑制効果を調査する.
- 分子レベルでMOF-酵素の相互作用のメカニズムを解明する.
主な方法:
- ChTに対する2D Cu (bpy) 2 (OTf) 2とZn (bim) 4ナノシートを用いて酵素阻害アッセイを行った.
- 阻害機構と酵素構造を分析するために,運動研究,光スペクトロスコーピー,および円形の二重化が使用されました.
- MOFと酵素の活性部位の相互作用を研究するために,UV-Vis光譜とイオン強度実験が使用されました.
主要な成果:
- 2D Cu ((bpy) 2 ((OTf) 2ナノシートでは,ChT活性が96. 9%抑制され,Zn2 ((bim) 4ナノシートは有意な効果を示さなかった.
- 運動分析は,MOFが競争性阻害剤として作用することを示した.
- 顕微鏡データは,MOFナノシートが酵素の二次構造を変化させないことを確認し,Cu (II) センターとHis-57との相互作用に起因する阻害を行った.
結論:
- 2-D Cu ((bpy)) 2 ((OTf)) 2のMOFナノシートは,主に酵素の活性部位との相互作用を通じて,競争的阻害によってChTを効果的に阻害します.
- この研究は,MOFの酵素活性調節の可能性を強調し,MOF-バイオインターフェースの探索のための基礎を提供します.
関連する概念動画
01:30Enzyme Inhibition
93.5K
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
93.5K
02:34Enzymes
96.0K
Inside living organisms, enzymes act as catalysts for many biochemical reactions involved in cellular metabolism. The role of enzymes is to reduce the activation energies of biochemical reactions by forming complexes with its substrates. The lowering of activation energies favor an increase in the rates of biochemical reactions.
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
96.0K
01:13Introduction to Mechanisms of Enzyme Catalysis
11.1K
For many years, scientists thought that enzyme-substrate binding took place in a simple "lock-and-key" fashion. This model stated that the enzyme and substrate fit together perfectly in one instantaneous step. However, current research supports a more refined view scientists call induced fit. The induced-fit model expands upon the lock-and-key model by describing a more dynamic interaction between enzyme and substrate. As the enzyme and substrate come together, their interaction causes...
11.1K
01:29Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
1.1K
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
1.1K